Terms: = Head and neck cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Prognosis
25 results:
1. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal cancer: A Systematic Review and Meta-Analysis.
Zhao Y; Song R; Jia Y; Zhang X; Zhang S; Wu C; Zhang R; Guo Z
Curr Oncol; 2022 Sep; 29(9):6610-6627. PubMed ID: 36135088
[TBL] [Abstract] [Full Text] [Related]
2. Simple cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract] [Full Text] [Related]
3. Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France.
Barin-Le Guellec C; Lafay-Chebassier C; Ingrand I; Tournamille JF; Boudet A; Lanoue MC; Defossez G; Ingrand P; Perault-Pochat MC; Etienne-Grimaldi MC
Eur J Cancer; 2020 Jan; 124():37-46. PubMed ID: 31715555
[TBL] [Abstract] [Full Text] [Related]
4. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8
Fukuoka E; Yamashita K; Tanaka T; Sawada R; Sugita Y; Arimoto A; Fujita M; Takiguchi G; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2019 Aug; 39(8):4539-4548. PubMed ID: 31366557
[TBL] [Abstract] [Full Text] [Related]
6. [Outcome of postoperative adjuvant chemotherapy and surgery alone for patients with stage pT1b-3N0M0 squamous cell carcinoma of the thoracic esophagus].
Zhang JZ; Liu JF; Li HY
Zhonghua Wai Ke Za Zhi; 2018 Apr; 56(4):289-293. PubMed ID: 29562415
[No Abstract] [Full Text] [Related]
7. [Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal cancer].
Hikami S; Shiozaki A; Fujiwara H; Konishi H; Arita T; Kosuga T; Morimura R; Murayama Y; Komatsu S; Ikoma H; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Otsuji E
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1796-1798. PubMed ID: 29394779
[TBL] [Abstract] [Full Text] [Related]
8. Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Jpn J Clin Oncol; 2018 Mar; 48(3):259-264. PubMed ID: 29190352
[TBL] [Abstract] [Full Text] [Related]
9. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
Koo JS; Yoon JS
Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
[TBL] [Abstract] [Full Text] [Related]
10. [Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy - a case report].
Yamamoto Y; Tanaka H; Maruyama T; Matsuzaki H; Natsume T; Miyazaki A; Satoh Y; Satsuka T; Yoshioka T; Kanada Y; Otsuka R; Yanagihara A; Yokoyama M; Kobayashi T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2006-9. PubMed ID: 25731404
[TBL] [Abstract] [Full Text] [Related]
11. A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
Shirakawa T; Kato K; Nagashima K; Nishikawa A; Sawada R; Takahashi N; Shoji H; Sasaki Y; Honma Y; Iwasa S; Takashima A; Okita N; Hamaguchi T; Yamada Y; Shimada Y
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1207-15. PubMed ID: 25267597
[TBL] [Abstract] [Full Text] [Related]
12. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract] [Full Text] [Related]
13. [The efficacy of postoperative adjuvant chemotherapy for esophageal cancer with lymph node metastasis].
Honjo H; Haga N; Ishiguro T; Miyazaki T; Kumamoto K; Kumagai Y; Baba H; Ishibashi K; Tsuji Y; Ishida H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2098-100. PubMed ID: 23267989
[TBL] [Abstract] [Full Text] [Related]
14. [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].
Yoneda M; Fujiwara H; Shiozaki A; Komatsu S; Ichikawa D; Okamoto K; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Kokuba Y; Otsuji E
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2397-400. PubMed ID: 22202394
[TBL] [Abstract] [Full Text] [Related]
15. [A case of long-term survival after resection for postoperative solitary adrenal metastasis from esophageal adenocarcinoma].
Saito H; Shuto K; Ota T; Toma T; Ohira G; Natsume T; Uesato M; Akutsu Y; Kono T; Matsubara H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2406-8. PubMed ID: 21224588
[TBL] [Abstract] [Full Text] [Related]
16. prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
Park JW; Kim JH; Choi EK; Lee SW; Yoon SM; Song SY; Lee YS; Kim SB; Park SI; Ahn SD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):691-7. PubMed ID: 20888705
[TBL] [Abstract] [Full Text] [Related]
17. [Usefulness of induction chemotherapy followed by chemo-radiotherapy for patients with advanced cervical esophageal cancer].
Suzuki T; Miura A; Kato T; Izumi Y; Monma K; Kawano T
Gan To Kagaku Ryoho; 2010 Jan; 37(1):71-5. PubMed ID: 20087035
[TBL] [Abstract] [Full Text] [Related]
18. [Facial nerve monitoring in the parotidectomy].
Pons Y; Clément P; Crambert A; Conessa C
Rev Laryngol Otol Rhinol (Bord); 2010; 131(4-5):253-6. PubMed ID: 21866735
[TBL] [Abstract] [Full Text] [Related]
19. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract] [Full Text] [Related]
20. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
[TBL] [Abstract] [Full Text] [Related]
[Next]
